Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.

scientific article published on 15 December 2017

Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1111/EJN.13800
P8608Fatcat IDrelease_ocwwnkccdfeqrbf3owdpvzugqa
P698PubMed publication ID29247465

P50authorPatrick D SkosnikQ89656281
P2093author name stringMohini Ranganathan
Mohamed A Sherif
Jose A Cortes-Briones
P2860cites workLeft auditory cortex gamma synchronization and auditory hallucination symptoms in schizophreniaQ21262976
Biological insights from 108 schizophrenia-associated genetic lociQ24561833
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathologyQ24602238
Cannabis and psychosis/schizophrenia: human studiesQ24628837
Neurophysiological and Computational Principles of Cortical Rhythms in CognitionQ24630528
Control of synaptic function by endocannabinoid-mediated retrograde signalingQ26824698
Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficitsQ26830533
Temporal binding and the neural correlates of sensory awarenessQ28143658
Role of endogenous cannabinoids in synaptic signalingQ28185075
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication developmentQ28205016
The brainweb: phase synchronization and large-scale integrationQ28210063
Do septal neurons pace the hippocampal theta rhythm?Q28260070
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron typesQ28262858
Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal studyQ28264991
Neuronal oscillations in cortical networksQ28268592
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophreniaQ28275290
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjectsQ28276986
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoidsQ28282550
Visual Feature Integration and the Temporal Correlation HypothesisQ28292903
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responsesQ29618915
Recent advances in the phencyclidine model of schizophreniaQ29618917
Modulation of oscillatory neuronal synchronization by selective visual attentionQ29619468
Abnormal neural oscillations and synchrony in schizophreniaQ29619846
Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operationsQ29620030
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addictionQ30053550
Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.Q30377901
Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitabilityQ30388341
The effect of chronic cannabinoids on broadband EEG neural oscillations in humansQ30450059
Hierarchical organization of gamma and theta oscillatory dynamics in schizophreniaQ30454591
"Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humansQ30455650
Sensory gating impairments in heavy cannabis users are associated with altered neural oscillationsQ30459343
Abnormalities of neuronal oscillations and temporal integration to low- and high-frequency auditory stimulation in schizophreniaQ30467569
Long-range synchrony of γ oscillations and auditory hallucination symptoms in schizophrenia.Q30471758
Gamma frequency-range abnormalities to auditory stimulation in schizophreniaQ30481594
Sensory-evoked gamma oscillations in chronic schizophreniaQ30481764
Gamma-band auditory steady-state responses are impaired in first episode psychosisQ30487085
Properties and dynamics of inhibitory synaptic communication within the CA3 microcircuits of pyramidal cells and interneurons expressing parvalbumin or cholecystokinin.Q39869655
40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA ReceptorsQ40031007
Gamma oscillation deficits and the onset and early progression of schizophreniaQ40227588
Neural mechanisms of visual motion perception in primatesQ41518932
The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: insights from computational modelingQ41980313
Oscillations and filtering networks support flexible routing of informationQ42104457
Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine.Q42750058
Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: implications for experimental psychosisQ42941366
Asynchronous release of GABA via tonic cannabinoid receptor activation at identified interneuron synapses in rat CA1.Q43117339
Self-modulation of neocortical pyramidal neurons by endocannabinoidsQ43241797
Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.Q43677912
Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteersQ44201512
Cannabis use and psychosis: a longitudinal population-based study.Q44820509
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptomsQ45049153
Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1.Q45838779
Impaired gamma-band activity during perceptual organization in adults with autism spectrum disorders: evidence for dysfunctional network activity in frontal-posterior cortices.Q45910295
Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG.Q46039940
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosisQ46066555
Reduced communication between frontal and temporal lobes during talking in schizophreniaQ46297342
Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release.Q46366644
Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients.Q46402937
Reduced evoked gamma oscillations in the frontal cortex in schizophrenia patients: a TMS/EEG studyQ46593468
Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depressionQ46603581
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive functionQ46688426
Temporal structure in neuronal activity during working memory in macaque parietal cortexQ46782711
Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholismQ46881184
Coupling in the cortico-basal ganglia circuit is aberrant in the ketamine model of schizophreniaQ47715157
Genetic insights into the neurodevelopmental origins of schizophreniaQ47717598
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampusQ48107275
EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorderQ48135212
The effect of selective attention on the gamma-band auditory steady-state responseQ48143443
Neural Syntax: Cell Assemblies, Synapsembles, and ReadersQ30497706
A 40-Hz auditory potential recorded from the human scalpQ30501603
Human auditory evoked gamma-band magnetic fieldsQ30530993
Ketamine alters oscillatory coupling in the hippocampusQ30542045
High-frequency neural activity and human cognition: past, present and possible future of intracranial EEG researchQ30575740
Medial septum regulates the hippocampal spatial representationQ30656043
Mechanisms of human attention: event-related potentials and oscillationsQ30662212
The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humansQ30671268
Gamma and Beta Bursts Underlie Working MemoryQ30834241
"Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?Q32061890
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophreniaQ33537860
Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairmentQ33562576
Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophreniaQ33696761
Intermittent degradation in performance in schizophreniaQ33792071
Neuronal synchrony: a versatile code for the definition of relations?Q33839076
Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.Q33846961
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort studyQ33962711
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.Q33989898
Neural synchrony indexes disordered perception and cognition in schizophreniaQ34368405
Schizotaxia revisitedQ34455035
Brain rhythms connect impaired inhibition to altered cognition in schizophreniaQ34470675
Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortexQ34536072
Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia.Q34553680
Effects of marijuana on neurophysiological signals of working and episodic memoryQ34623119
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteersQ34639448
Gamma Oscillatory Power is Impaired During Cognitive Control Independent of Medication Status in First-Episode SchizophreniaQ34661399
Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamineQ34661613
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptomsQ34662055
It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and PsychosisQ34675621
Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticityQ34691684
Human auditory steady-state responsesQ35147023
Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells.Q35575211
Molecular abnormalities of the glutamate synapse in the thalamus in schizophreniaQ35610988
Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in miceQ48155702
Induced gamma activity and event-related coherence in schizophreniaQ48161538
Neuroelectromagnetic correlates of perceptual closure processes.Q48162475
Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons.Q48291065
Cannabinoids reveal importance of spike timing coordination in hippocampal functionQ48364611
Resting-state theta-band connectivity and verbal memory in schizophrenia and in the high-risk stateQ48393394
Psychophysiological evidence of altered neural synchronization in cannabis use: relationship to schizotypyQ48407943
A mechanism of deficient interregional neural communication in schizophreniaQ48417507
Working memory related gamma oscillations in schizophrenia patientsQ48425014
Low-frequency EEG oscillations associated with information processing in schizophreniaQ48426825
Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia.Q48499981
Visually induced gamma-band responses to coherent and incoherent motion: a replication studyQ48655317
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysisQ48655780
Simulations of cortical pyramidal neurons synchronized by inhibitory interneuronsQ48668501
Event-related theta oscillations during working memory tasks in patients with schizophrenia and healthy controlsQ48694874
Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processingQ48731793
Interactive effects of subanesthetic ketamine and haloperidol in healthy humansQ48746210
Dysfunctional prefrontal cortical network activity and interactions following cannabinoid receptor activation.Q48818952
Decreased functional connectivity of EEG theta-frequency activity in first-episode, neuroleptic-naïve patients with schizophrenia: preliminary resultsQ48865796
Relationship between steady-state and induced gamma activity to motionQ48941622
Steady state visual evoked potential abnormalities in schizophreniaQ49034070
Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.Q50735793
Theta rhythm: a temporal correlate of memory storage processes in the rat.Q51107822
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.Q51536942
The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.Q51750311
The effect of cannabis use and gender on the visual steady state evoked potential.Q51827477
Cannabinoid modulations of resting state EEG θ power and working memory are correlated in humans.Q51889926
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.Q51902545
Illy: clinical and public health implications of a street drug.Q51906121
Evoked gamma band synchronization and the liability for schizophrenia.Q51938025
EEG phase synchrony differences across visual perception conditions may depend on recording and analysis methods.Q51995797
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.Q52023779
Gamma-band synchronization in visual cortex predicts speed of change detection.Q52030620
Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.Q52585058
Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherenceQ57403278
Modulation of induced gamma band activity in the human EEG by attention and visual information processingQ57721895
Selective visual-spatial attention alters induced gamma band responses in the human EEGQ57721901
Gamma oscillation in schizophrenia.Q35634284
Oscillatory synchrony and human visual cognitionQ35650540
Fine structure of neural spiking and synchronization in the presence of conduction delaysQ35802767
On the formation of gamma-coherent cell assemblies by oriens lacunosum-moleculare interneurons in the hippocampusQ35941304
Microcircuits in action--from CPGs to neocortexQ36238814
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophreniaQ36245009
An evaluation of phencyclidine (PCP) psychosis: a retrospective analysis at a state facilityQ36664858
Effects of working memory load on oscillatory power in human intracranial EEG.Q36775116
A neural coding scheme formed by the combined function of gamma and theta oscillations.Q36842930
Patterns of spontaneous magnetoencephalographic activity in patients with schizophreniaQ36881922
Reduced Brain Cannabinoid Receptor Availability in SchizophreniaQ36945634
Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalitiesQ36990973
Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophreniaQ37076431
Magnetoencephalographic gamma power reduction in patients with schizophrenia during resting conditionQ37356297
Modulation of long-range neural synchrony reflects temporal limitations of visual attention in humansQ37512612
Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophreniaQ37846896
γ oscillations in schizophrenia: mechanisms and clinical significance.Q37917218
Cortical basket cell dysfunction in schizophreniaQ37973314
Anandamide dysfunction in prodromal and established psychosisQ38020218
Oscillatory multiplexing of population codes for selective communication in the mammalian brainQ38179236
Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunitiesQ38353448
Ketamine disrupts θ modulation of γ in a computer model of hippocampus.Q38537612
Impaired theta-gamma coupling during working memory performance in schizophreniaQ38763234
Rhythms of the hippocampal networkQ38767515
Human Laboratory Studies on Cannabinoids and Psychosis.Q38771523
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective studyQ39680990
Changes in brain network activity during working memory tasks: a magnetoencephalography study.Q39821326
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectcannabinoidsQ422936
P304page(s)2890-2902
P577publication date2018-01-11
P1433published inEuropean Journal of NeuroscienceQ5412733
P1476titleCannabinoid-glutamate interactions and neural oscillations: implications for psychosis
P478volume48

Reverse relations

cites work (P2860)
Q92130252Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis
Q92627340Opportunities for cannabis in supportive care in cancer

Search more.